Abstract
Background: Chemotherapy (CT) or radiotherapy (RT) induced cardiotoxicity (Cx) is a clinical challenge and currently is diagnosed by the reduction of left ventricular ejection fraction (EF). However, early and even subclinical risk stratification is of particular relevance since the presence of myocardial damage influences the management and prognosis of these patients (pts).